PULMONARY ARTERY DIAMETER ON CHEST CT PREDICTS IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA

Nart Zafer Baytugan, Aziz Inan Celik, Tahir Bezgin

Abstract


Background: Enlargement of the pulmonary artery (PA) could be helpful in risk stratification by the chest CT on the admission of COVID-19 patients.

Methods: This study aimed to associate PA diameter and overall mortality in COVID-19 pneumonia. We designed a retrospective study between January 2021 and May 2021 in tertiary-level hospitals in Gebze, Turkey. Subjects were evaluated in two groups according to their survivor status (survivors and non-survivors). Then biochemical, demographic, and clinical values were compared via the groups to define the predictive value of PA diameter on chest CT images.

Results: In the enrolled 594 COVID-19 in-hospital patients (median age was 45 (34-58) years, 263patients (44.3%) were female. 44 patients (7.4%) died during hospitalization. Multivariate Cox-proportion regression model yielded main PA ≥ 29 mm on admission showed that as independent predictors of death (long rank <0.001, median survival time 28 days). Cumulative survival rates were MPAD ≥ 29 mm 45% and < 29 mm 90% yielded (p < 0.001)

Conclusions: PA dilatation is strongly linked with in-hospital mortality in hospitalized patients with COVID-19 infection. Thus increased PA diameter on chest CT at admission may guide rapid and early diagnosis of high-risk patients.


Keywords


COVID-19, Computed tomography, pulmonary artery, mortality, pneumonia

Full Text:

PDF

References


Pradhan D, Biswasroy P, Kumar Naik P, Ghosh G, Rath G. A review of current interventions for COVID-19 prevention. Arch Med Res. 2020;51(5):363-74. doi: 10.1016/j.arcmed.2020.04.020.

Sharma A, Tiwari S, Deb MK, Marty JL.Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054. doi: 10.1016/j.ijantimicag.2020.106054.

Libby P, Lüscher T.COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41(32):3038-44. doi: 10.1093/eurheartj/ehaa623.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13): 1239–42. doi: 10.1001/jama.2020.2648.

Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15(11): e0241955. doi: 10.1371/journal.pone.0241955.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229): 1054–62. doi: 10.1016/S0140-6736(20)30566-3.

Ufuk F, Savas R. Chest CT features of the novel coronavirus disease (COVID-19). Turk J Med Sci.2020 ;50(4):664-78. doi: 10.3906/sag-2004-331.

Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by the duration of symptoms. Eur J Radiol 2020;127:109009. doi: 10.1016/j.ejrad.2020.109009

Chien CH,Shih FC, Chen CY,Chen CH, Wu WL, Mak CW.Unenhanced multidetector computed tomography findings in acute central pulmonary embolism. BMC Med Imaging. 2019;19(1):65. doi: 10.1186/s12880-019-0364-y.

Zhu QQ, Gong T, Huang G, Niu ZF, Yue T, Xu FY et al. Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19. Jpn J Radiol. 2021;39(6):589-97. doi: 10.1007/s11604-021-01094-9.

Truong QA, Bhatia SH, Szymonifka J, Zhou Q, Lavender Z, Waxman AB, et al. A Four-Tier Severity Classification System of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension. J Cardiovasc Comput Tomogr. 2018;12(1): 60–6. doi: 10.1016/j.jcct.2017.12.001.

Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. 2020;296(2):115-7. doi: 10.1148/radiol.2020200432.

Yildiz M, Yadigar S, Yildiz BÅž, Aladag NB, Keskin O, Ozer RS, et al. Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement. Herz. 2021;46(1):56-62. doi: 10.1007/s00059-020-05014-x.

Nevsky G, Jacobs JE, Lim RP, Donnino R, Babb JS, Srichai MB. Sex-specific normalized reference values of heart and great vessel dimensions in cardiac CT angiography. AJR Am J Roentgenol. 2011;196(4):788-94. doi: 10.2214/AJR.10.4990.

Esposito A, Palmisano A, Toselli M, Vignale D, Cereda A, Rancoita PMV, et al. Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy. Eur Radiol. 2021;31(6):4031-41. doi: 10.1007/s00330-020-07622-x.

Erdoğan M, Öztürk S, Erdöl MA, Kasapkara A, Beşler MS, Kayaaslan B, et al. Prognostic utility of pulmonary artery and ascending aorta diameters derived from computed tomography in COVID-19 patients. Echocardiography. 2021;38(9):1543-51. doi: 10.1111/echo.15170.

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19:Abnormal liver function test. J Hepatol. 2020;73(3):566-74. doi: 10.1016/j.jhep.2020.04.006.

Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145-8. doi: 10.1016/j.cca.2020.03.022.

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-47. doi: 10.1002/ajh.25829.

Ruan Q, Yang K, Wang W Jiang L. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–8. doi: 10.1007/s00134-020-05991-x.




DOI: http://dx.doi.org/10.5937/sanamed17-38017

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Nart Zafer Baytugan

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.